Macquarie Group Limited 13D and 13G filings for Supernus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-01 4:35 pm Sale |
2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Macquarie Group Limited | 2,631,897 4.780% |
-105,824 (-3.87%) |
Filing |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Macquarie Group Limited | 2,737,721 5.010% |
2,737,721 (New Position) |
Filing |